Oxford Technology Management
Investor profile
Oxford Technology Management has backed 6 European tech companies across 7 funding rounds between 2017 and 2026, joining rounds totalling €23M. Most active in Healthtech and Cleantech. Data as of Nov 2026.
Also recorded as: Oxford Technology
Deals
7
distinct rounds
Companies
6
backed
Active span
2017–2026
10 yrs
Total round €
€23M
sum of rounds joined
Deals by year
distinct rounds / yearOxford Technology Management — deals by year — interactive chart.
Data table
| Oxford Technology Management — deals by year | |
|---|---|
| 2017 | 1 |
| 2018 | 1 |
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 1 |
| 2024 | 1 |
| 2026 | 1 |
Top sectors
by dealsOxford Technology Management — top sectors — interactive chart.
Data table
| Oxford Technology Management — top sectors | |
|---|---|
| Healthtech | 5 |
| Cleantech | 1 |
| Software | 1 |
Stages
by dealsOxford Technology Management — stages — interactive chart.
Data table
| Oxford Technology Management — stages | |
|---|---|
| Other | 3 |
| Seed | 2 |
| Growth/Late | 1 |
| Series A | 1 |
Countries
by dealsOxford Technology Management — countries — interactive chart.
Data table
| Oxford Technology Management — countries | |
|---|---|
| UK | 7 |
Co-investment network
shared roundsCo-investment network — interactive chart.
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
Frequent co-investors
shared rounds- 24Haymarket1
- AlbionVC1
- Cancer Research UK1
- Citi Institutional Strategic Investments1
- Civilisation Ventures1
- Clean Growth Fund1
- Eka Ventures1
- First Imagine1
- Foxglove Capital1
- Francis Crick Institute1
- Genoa Ventures1
- Greenwood Way Capital1
- Headington Holdings1
- Hygea VCT1
- Innovations EIS Fund1
- Invesco1
- IP Group1
- LifeArc Ventures1
- Longevitytech.fund1
- MegaRobo1
- MegaRobo Technologies1
- Oxford Capital Partners1
- Oxford Technology and Innovations EIS Fund (OTIF)1
- Oxford University1
- Oxonian1
Portfolio
top 30 by total round €| Company | Country | Rounds | Total € |
|---|---|---|---|
| HydRegen | UK | 1 | €7.1M |
| DiffBlue | UK | 1 | €5.8M |
| Oxcan | UK | 2 | €4.9M |
| Glide Pharmaceutical Technologies | UK | 1 | €3.7M |
| Sphere Fluidics | UK | 1 | €1.7M |
| MitoRx Therapeutics | UK | 1 | €0 |
Biggest deals
top 10 by amount| Company | Stage | Amount | Date |
|---|---|---|---|
| DiffBlue | Other | €5.8M | 2024-10 |
| Glide Pharmaceutical Technologies | Growth/Late | €3.7M | 2017-02 |
| Oxcan | Other | €3.5M | 2023-01 |
| Sphere Fluidics | Other | €1.7M | 2019-01 |
| Oxcan | Seed | €1.5M | 2021-09 |